Lymphomatoid Papulosis

Explore clinical trials studying Lymphomatoid Papulosis. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Lymphomatoid Papulosis trial results

Recruiting

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

NCT06207812

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

NCT03587844

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Stanford University Medical Center Stanford, California, United States

Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

View Trial Details

Recruiting

Tissue Repository: CTCL Collection Protocol

NCT02840747

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Completed

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

NCT03409432

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +18 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma

NCT00099255

Conditions: Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of California at Los Angeles Los Angeles, California, United States

Stanford University Stanford, California, United States

Yale New Haven, Connecticut, United States

View all 13 locations

View Trial Details

Active, Not Recruiting

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

NCT01352520

Conditions: CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma, Cutaneous Lymphomas, Hematologic Diseases, +16 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

NCT03602157

Conditions: Cutaneous Anaplastic Large Cell Lymphoma, Cutaneous Lymphoma, Cutaneous T Cell Lymphoma, +15 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Lymphomatoid Papulosis

Lymphomatoid Papulosis trial results

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Tissue Repository: CTCL Collection Protocol

Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma

Study of SGN-30 (Anti-CD30 mAb) in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma

SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP)

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Related conditions